06/03/2015 00:58:19 Free Membership Login

Xenoport News (NASDAQ:XNPT)

DateTimeSource
Headline
02/23/201510:00AMBWXenoPort to Present at the Cowen and Company 35th Annual Health Care Conference
XenoPort, Inc. (NASDAQ: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Cowen and Company 35th Annual Health Care Conference. The live presentation will occur at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on Wednesday, March 4, 2015. A replay of the presentation... More...>>
02/19/20154:05PMBWXenoPort Reports Fourth Quarter and Year-End 2014 Financial Results
XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2014. Revenues for the fourth quarter were $7.1 million compared to $2.9 million for the same period in 2013. Net loss for the fourth quarter was $17.7 million compared to a net loss of $19.1 million for... More...>>
02/18/20154:30PMBWXenoPort to Present at the RBC Capital Markets’ Global Healthcare Conference
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the RBC Capital Markets’ Global Healthcare Conference. The live presentation will occur at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time) on Wednesday, February 25, 2015. A replay of the presentation... More...>>
02/05/201510:00AMBWXenoPort to Release Fourth Quarter and Year-End Financial Results on February 19, 2015
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its fourth quarter and year-end financial results on February 19, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business... More...>>
01/29/20159:00AMBWXenoPort Announces Pricing of $100 Million 2.50% Convertible Senior Notes due 2022
XenoPort, Inc. (NASDAQ: XNPT) announced today the pricing of $100 million aggregate principal amount of 2.50% Convertible Senior Notes due 2022 in a private placement to qualified institutional buyers pursuant to Rule 144A (the “offering”) under the Securities Act of 1933, as amended (the “Securities Act”). In... More...>>
01/28/20154:36PMBWXenoPort Announces Proposed Offering of $100 Million Convertible Senior Notes due 2022
XenoPort, Inc. (Nasdaq: XNPT) announced today that it intends to offer, subject to market and other conditions, $100 million aggregate principal amount of convertible senior notes due 2022 in a private placement to qualified institutional buyers pursuant to Rule 144A (the “offering”) under the Securities Act of 1933... More...>>
01/11/20151:00PMBWXenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder
XenoPort (NASDAQ:XNPT) today reported an update on prescription trends and further development of HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, including feedback from the U.S. Food and Drug Administration (FDA) on development for treatment of alcohol use disorder (AUD). HORIZANT prescription trend highlights... More...>>
11/06/20141:09PMBWXenoPort to Present at the Credit Suisse Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Credit Suisse Healthcare Conference in Phoenix, Arizona. The live presentation will occur at 8:30 a.m. Pacific Time (9:30 a.m. Mountain Time) on Wednesday, November 12, 2014. A replay of the presentation... More...>>
11/04/20144:06PMBWXenoPort Reports Third Quarter Financial Results
Reports Significant Year-Over-Year HORIZANT Sales Growth XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2014. Revenues for the third quarter were $31.1 million compared to $2.5 million for the same period in 2013. Revenues for the third quarter... More...>>
10/23/201410:00AMBWXenoPort to Release Third Quarter Financial Results on November 4
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2014 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A... More...>>
09/10/20148:30AMBWXenoPort to Present Data for Novel Fumarate Analog XP23829 at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data on XP23829, an investigational prodrug of monomethyl fumarate (MMF), at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston. Data being presented include the results from a clinical trial evaluating the safety, tolerability and pharmacokinetics of XP23829... More...>>
09/09/20148:30AMBWXenoPort and the NIAAA Announce Clinical Trial Agreement to Study HORIZANT as a Potential Treatment for Alcohol Use Disorder
XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that they have entered into an agreement to conduct a clinical trial of HORIZANT® (gabapentin enacarbil) Extended-Release Tablets as a potential treatment for alcohol use disorder (AUD). Under the terms of the... More...>>
09/02/201411:00AMBWXenoPort to Present at the Morgan Stanley Global Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 1:40 p.m. Pacific Time (4:40 p.m. Eastern Time) on Tuesday, September 9, 2014. A replay of the presentation will also... More...>>
08/06/20144:05PMBWXenoPort Reports Second Quarter Financial Results
HORIZANT Net Product Sales Increased 66% Over First Quarter 2014 XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the second quarter and six months ended June 30, 2014. Total revenues for the second quarter were $5.3 million, compared to $2.1 million for the same period in 2013. Net loss for the second... More...>>
07/22/201412:00PMBWXenoPort to Release Second Quarter Financial Results on August 6, 2014
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its second quarter financial results on August 6, 2014 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day. A replay of the call will be available for one week following the event. To access... More...>>
06/23/20148:30AMBWXenoPort Announces Initiation of a Phase 2 Clinical Trial of XP23829 in Patients With Psoriasis
XenoPort, Inc. (Nasdaq: XNPT) announced today that it has initiated a Phase 2 clinical trial of XP23829, its proprietary investigational next-generation fumaric acid product candidate. The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of XP23829 as... More...>>
06/11/20141:06PMBWStockholders Elect ALL Three XenoPort Director Nominees at Annual Meeting
None of Clinton’s Three Nominees Were Elected XenoPort, Inc. (Nasdaq: XNPT) today announced that, based on the estimated vote count provided by its proxy solicitor, stockholders have elected by a wide margin all of the XenoPort director nominees at the Company’s 2014 Annual Meeting of Stockholders: Ronald W. Barrett... More...>>
06/09/201410:00AMBWXenoPort to Present at the 2014 Wells Fargo Healthcare Conference
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Wells Fargo Healthcare Conference. The live presentation will occur at 11:25 a.m. Pacific Time (2:25 p.m. Eastern Time) on Wednesday, June 18, 2014. A replay of the presentation will also be... More...>>
06/06/20148:30AMBWXenoPort Urges Stockholders to Vote "FOR ALL" XenoPort Director Nominees on the WHITE Proxy Card
XenoPort, Inc. (Nasdaq:XNPT) today reminded stockholders to vote at the Company’s upcoming Annual Meeting of Stockholders on June 11, 2014. Time is short and stockholders are encouraged to vote the WHITE proxy card today. XenoPort urges stockholders not to return any proxy card sent to them by Clinton Relational Opportunity... More...>>
06/05/20148:44AMPRNUSCEO Has Special Incentive to Spend on Horizant, Says Clinton Group
CEO Has Special Incentive to Spend on Horizant, Says Clinton Group PR Newswire NEW YORK, June 5, 2014 NEW YORK, June 5, 2014 /PRNewswire/ -- Clinton Group, Inc. ("Clinton Group") announced today that it has sent a letter to the stockholders of XenoPort, Inc. (Nasdaq: XNPT) in advance of the June 11, 2014 XenoPort annual... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq xnpt150306 00:58